Crossmark

Quality of prescribing and health-related quality of life in older adults: a narrative review with a special focus on patients with atrial fibrillation and multimorbidity

Crossref DOI link: https://doi.org/10.1007/s41999-025-01175-2

Published Online: 2025-03-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Amrouch, Cheima https://orcid.org/0000-0001-6708-7372
Lane, Deirdre A.

Calderón-Larrañaga, Amaia

Petrovic, Mirko

De Smedt, Delphine

,
Funding

Funding for this research was provided by:

Horizon 2020 Framework Programme (899871)
License Information

Text and Data Mining valid from 2025-03-09

Version of Record valid from 2025-03-09
More Information

Article History

Received: 11 October 2024

Accepted: 13 February 2025

First Online: 9 March 2025

Declarations

:

: DAL has received investigator-initiated quality improvement grants from Pfizer and Bristol-Myers Squibb (BMS), has been a speaker for Bayer, Boehringer Ingelheim, and BMS/Pfizer and has consulted for BMS and Boehringer Ingelheim, all outside the submitted work. CA, AC-L, DDS and MP have no conflict of interest that might be relevant to this manuscript.

: Not applicable.

Document is current

Any future updates will be listed below